The U.S. Food and Drug Administration approved the first autonomous artificial intelligence diagnostic system, IDx-DR and the University of Iowa Healthcare has become the first healthcare organization to implement it.
Ibrutinib plus venetoclax (ABT-199) improves outcomes over standard therapy in patients with mantle-cell lymphoma (MCL) and a poor prognosis reports a new research in the New England Journal of Medicine.
An analysis of Bayer's XANTUS programme revealed the safety profile of the oral Factor Xa inhibitor Xarelto® (rivaroxaban) in clinical practice.
A new study by University of Alberta scientists found major potential in a fresh and potent class of chemical compounds for treating Zika virus and respiratory syncytial virus (RSV).
Autoimmune hepatitis is a chronic disease more commonly seen in females, where the human body’s immune system goes awry and attacks its healthy liver cells. This immune response causes hepatitis i.e. inflammation of the liver. If left untreated, this disease can result in complications such as cirrhosis of the liver and/or hepatic failure.
iBeat, a San Francisco-based start-up, launched a new pulse sensitive feature called iBeat Heart Watch which alerts healthcare professionals if it detects someone going into cardiac arrest.
Bristol-Myers Squibb’s recent immunotherapy combo won FDA approval for patients with a rare colon cancer. The combinational medicine was formulated between an older medicine named Yervoy and a new cancer-fighter Opdivo. This combo drug focuses on repairing the mismatch gene.
Onychomycosis is a fungal infection that causes nail disfigurement, pain and infection and impacts millions of people throughout the world. Though several antifungal treatments are currently available, they often fail for various reasons.
Hepatitis is defined as liver inflammation usually caused by the hepatitis virus. There are of 5 types of hepatitis: A, B, C, D and E. At times, our own immune system will attack the liver, which is termed as autoimmune hepatitis disease. Common symptoms include fever, jaundice, fatigue, abdominal pain, dark urine, pale stool, loss of appetite and weight loss.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.